AtaiBeckley Inc. CEO Dr Srinivas Rao joined Steve Darling from Proactive to discuss topline results from...
13.40 Tue 03 Mar 2026
AtaiBeckley Inc. CEO Dr Srinivas Rao joined Steve Darling from Proactive to discuss topline results from the company’s exploratory, double-blind, placebo-controlled Phase 2a trial evaluating EMP-01 in adults with Social Anxiety Disorder (SAD).The first-in-patient study met its primary safety...